# Analyst A review of Analyst B's pathway redesign

Reviewed 27 October 2026 (America/Chicago); B's handoff is dated 28 October 2026 UTC.
Base release: `6c07655483819377642b609a215f54662e181654`.

## Scope and reconciliation

Analyst B is Claude.ai. Its new transplant redesign was inspected in the Claude app and reconciled with its shared-folder handoff and patch. Analyst A is Codex. No internal agent was substituted for B.

The user's terminology is retained: **roadmaps** are cancer roadmaps; **pathways** are transplant pathways. The latest roadmap layout is the visual reference for the seven pathways.

| B proposal | A assessment |
| --- | --- |
| Four journey groups above numbered decision buttons | Accepted. All 45 combined navigation destinations remain selectable; the separate legacy HCC waitlist link also opens its source decision, covering all 46 clinical decisions. |
| One card containing question, context and three columns | Accepted. Consistent with the roadmap hierarchy. |
| Blue findings, criteria, colored result, then evidence | Accepted. Blue input does not imply eligibility or a recommendation. |
| Move Reasons to reassess directly below the result | Accepted. The entire panel remains immediately visible, before Other possible results and outcome evidence. It is not collapsed or moved into a tooltip. |
| Hide an exactly repeated help sentence | Accepted only for exact normalized text equality; the sourced criteria remain. |
| High-risk distinction | Orange headings and contextual routes retained. |
| Shared cache refresh | Accepted across roadmaps and pathways. The new layout activates only on pathway pages, preserving the current roadmap design. |

This is a presentation review. Clinical criteria, source text, eligibility matching and next-action rules were not revised.

## Independent verification

- All 17 Node suites and six Python suites passed.
- All 29 protected clinical-source files match the established baseline.
- Browser review: 45 combined pathway navigation destinations plus the legacy HCC waitlist decision; all have the expected card, order, result and fully visible reassessment panel.
- A finding was selected and confirmed in all seven pathways. Next-step controls were exercised; three first findings completed the decision and navigated to the next clinical question, while the four incomplete decisions correctly remained pending.
- All 103 clinical topics across 12 roadmaps were opened; 769 treatment-control views and 309 recommendation groups were inspected. No missing compact result lines or pathway-only style leakage.
- Phone: 57 tab checks across all 19 roadmap/pathway pages at 390 × 844. No page-level horizontal overflow.
- HCC Milan, T2 and UNOS-downstaging criteria and source links remain expanded/accessible; the LR-5 explanation opens correctly.
- High-risk headings retain computed orange `rgb(168, 71, 10)`.
- Systemic matrix retains 49 regimen cards. Browser warnings/errors: none in the checked preview session.
- Detailed JSON logs and screenshots are saved beside this review.

The supplied Python browser test was retained in the repository. A's interactive checks used the Codex browser interface instead of executing that test. No clinical approval by B, C, D or E is claimed.
